The Janus face of HMGB1 in heart disease: a necessary update

Perché è importante capire meglio il ruolo di questa proteina nucleare nelle disfunzioni cardiache. (Cell Mol Life Sci 2018 Oct 10)

17 Ottobre Ott 2018 one month ago
  • Raucci A, Di Maggio S, Scavello F

High mobility group box 1 (HMGB1) is a ubiquitous nuclear protein involved in transcription regulation, DNA replication and repair and nucleosome assembly. HMGB1 is passively released by necrotic tissues or actively secreted by stressed cells.

Extracellular HMGB1 acts as a damage-associated molecular pattern (DAMPs) molecule and gives rise to several redox forms that by binding to different receptors and interactors promote a variety of cellular responses, including tissue inflammation or regeneration. Inhibition of extracellular HMGB1 in experimental models of myocardial ischemia/reperfusion injury, myocarditis, cardiomyopathies induced by mechanical stress, diabetes, bacterial infection or chemotherapeutic drugs reduces inflammation and is protective. In contrast, administration of HMGB1 after myocardial infarction induced by permanent coronary artery ligation ameliorates cardiac performance by promoting tissue regeneration. HMGB1 decreases contractility and induces hypertrophy and apoptosis in cardiomyocytes, stimulates cardiac fibroblast activities, and promotes cardiac stem cell proliferation and differentiation.

Interestingly, maintenance of appropriate nuclear HMGB1 levels protects cardiomyocytes from apoptosis by preventing DNA oxidative stress, and mice with HMGB1cardiomyocyte-specific overexpression are partially protected from cardiac damage.

Finally, higher levels of circulating HMGB1 are associated to human heart diseases. Hence, during cardiac injury, HMGB1 elicits both harmful and beneficial responses that may in part depend on the generation and stability of the diverse redox forms, whose specific functions in this context remain mostly unexplored.

This review summarizes recent findings on HMGB1 biology and heart dysfunctions and discusses the therapeutic potential of modulating its expression, localization, and oxidative-dependent activities. Preliminary data indicate that maintenance of higher nuclear HMGB1 content protects CMs from apoptosis induced by Dox and detrimental hypertrophic stimuli by preventing DNA oxidative damage [114]. Thus, understanding how cells may preserve a proper level of nuclear HMGB1 to sustain efficient DNA repair may help to understand the progression of cardiac diseases.


Reference
1. Raucci A, Di Maggio S, Scavello F, D'Ambrosio A, Bianchi ME, Capogrossi MC. The Janus face of HMGB1 in heart disease: a necessary update. Cell Mol Life Sci 2018 Oct 10. doi: 10.1007/s00018-018-2930-9. [Epub ahead of print] Go to PubMed